Family Medicine Doctors in Columbia, MO Accepting Medicare

187 Family Medicine doctors found. Showing 181 - 187

John Daniel Bocinsky, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 551 E Southampton Dr # Dc106.00, Columbia, MO 65201 Phone: 573-884-7733    Fax: 573-882-6228

Michael L Lefevre, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 East Southampton Drive, Columbia, MO 65201 Phone: 573-884-7733    Fax: 573-882-6228

Dr. Justin E. Jones, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1605 E Broadway, Suite 110, Columbia, MO 65201 Phone: 573-815-8130    Fax: 573-815-8149

Elizabeth Sherman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr # Dc032.00, Columbia, MO 65212 Phone: 573-884-2912

Jamie Alise Ogden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2325 Smiley Ln, Columbia, MO 65202 Phone: 573-884-8980    Fax: 573-884-0040

Kathleen Wlaton David, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 303 N Keene St, Suite 301, Columbia, MO 65201 Phone: 573-449-0808    Fax: 573-442-1331

Dr. Geoffrey Daniel Newcomb, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-9338

News Archive

GSK to deploy BioClinica's Trident IWR system across Phase I-IV clinical trials

BioClinica®, Inc.,, a global provider of clinical trial management services, today announced that GlaxoSmithKline LLC ("GSK") has signed a multi-year enterprise technology agreement to deploy BioClinica's Trident IWR (Interactive Web Response) system across its Phase I-IV clinical trials.

Aortic valve replacement is safe to treat severe aortic stenosis in very eldery patients

Aortic valve replacement (AVR) can safely be used to treat severe aortic stenosis in patients age 90 years and older and is associated with a low risk of operative stroke and mortality, according to a study in the November 2014 issue of The Annals of Thoracic Surgery.

FDA issues guidance for medical product developers to address the emergence of SARS-CoV-2 variants

Today, the U.S. Food and Drug Administration issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19.

FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10(current)